Hospitalized and Fatal HF | Treated, Nonhospitalized HF | Without HF* | ||||
---|---|---|---|---|---|---|
C | D | C | D | C | D | |
No. of subjects | 327 | 346 | 93 | 145 | 14493 | 8347 |
Age, years, mean (SD) | 70.7 (8.3) | 71.0 (8.6) | 70.3 (8.2) | 69.9 (7.2) | 66.8 (7.6) | 66.6 (7.6) |
Race | ||||||
White, non-Hispanic, % | 61.2 | 55.8 | 63.4 | 64.8 | 47.3 | 46.3 |
Black, non-Hispanic, % | 30.6 | 35.3 | 32.3 | 30.3 | 32.0 | 32.9 |
Hispanic, % | 4.6 | 5.5 | 2.2 | 2.8 | 15.6 | 16.1 |
Other, % | 3.7 | 3.1 | 2.2 | 2.1 | 5.1 | 4.8 |
Women, % | 42.8 | 39.6 | 33.3 | 44.1 | 47.0 | 46.5 |
Education, years, mean (SD) | 10.5 (3.9) | 10.7 (3.4) | 11.3 (3.6) | 12.1 (3.2) | 11.0 (4.0) | 11.0 (4.0) |
Cigarette smoking, current, % | 19.0 | 19.4 | 11.8 | 17.9 | 22.1 | 21.9 |
Antihypertensive treatment | ||||||
Treated > 2 months, % | 86.9 | 86.8 | 95.7 | 95.2 | 86.9 | 86.7 |
Treated < 2 months, % | 3.3 | 3.3 | 1.1 | 0.0 | 3.3 | 3.3 |
Untreated, % | 9.8 | 10.0 | 3.2 | 4.8 | 9.9 | 10.0 |
Blood pressure, mm Hg, mean (SD) | 147.8/81.1 (17.6/10.9) | 150.1/81.8 (16.5/11.0) | 147.1/82.2 (16.0/10.5) | 145.9/82.0 (15.8/10.6) | 146.2/84.1 (15.6/10.0) | 146.1/84.1 (15.7/10) |
Pulse pressure, mm Hg, mean (SD) | 66.7 (16.5) | 68.3 (15.3) | 64.9 (13.0) | 63.9 (15.3) | 62.1 (14.1) | 62.1 (14.2) |
Eligibility risk factors† | ||||||
LVH | ||||||
By electrocardiogram, % | 20.5 | 22.3 | 18.3 | 21.4 | 16.1 | 16.1 |
By echocardiogram, % | 6.3 | 4.7 | 4.4 | 1.4 | 4.6 | 4.6 |
Old MI or stroke, % | 36.1 | 34.7 | 41.9 | 33.1 | 23.1 | 22.3 |
CABG/Angioplasty, % | 22.6 | 18.5 | 25.8 | 26.2 | 12.9 | 12.6 |
ASCVD, % | 33.3 | 29.2 | 31.2 | 31.0 | 23.4 | 24.6‡ |
Type 2 diabetes, % | 46.8 | 48.3 | 43.0 | 40.7 | 35.9 | 34.7 |
HDL<35 mg/dl, % | 12.8 | 13.6 | 14.0 | 13.8 | 11.9 | 11.7 |
ST-T wave changes, % | 12.8 | 10.6 | 10.9 | 12.9 | 10.4 | 10.2 |